Baricitinib vs Rosuvastatin

Baricitinib vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between Baricitinib and Rosuvastatin.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Rosuvastatin — 19 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Rosuvastatin — C22H28FN3O6S.

Molecular Weight: Baricitinib — 371.4170 g/mol; Rosuvastatin — 481.5390 g/mol.

Type: Baricitinib — Small molecule; Rosuvastatin — Small molecule.